Myc but not Fos rescue of PDGF signalling block caused by kinase-inactive Src
- PMID: 7477410
- DOI: 10.1038/378509a0
Myc but not Fos rescue of PDGF signalling block caused by kinase-inactive Src
Abstract
Growth factors such as platelet-derived growth factor (PDGF) elicit the transcriptional activation of a large number of immediate early genes (many of which encode transcription factors), and ultimately DNA synthesis. Both AP1 and Myc are activated in fibroblasts in response to growth factor stimulation, and various experiments suggest their importance in proliferation. Src family kinases are required for PDGF (and other growth factors) to induce DNA synthesis. We have examined which transcription factors, when constitutively expressed, 'rescue' the block elicited by dominant negative Src. We report here that Myc, but not Fos and/or Jun, was able to rescue the block. In contrast, Fos and Jun, but not Myc, rescued the block induced by dominant negative Ras. Our data suggest that Src kinases control the transcriptional activation of Myc.
Comment in
-
Signal transduction. Beating a path to Myc.Nature. 1995 Nov 30;378(6556):438-9. doi: 10.1038/378438a0. Nature. 1995. PMID: 7477397 No abstract available.
Similar articles
-
Regulation of c-myc expression by PDGF through Rho GTPases.Nat Cell Biol. 2001 Jun;3(6):580-6. doi: 10.1038/35078555. Nat Cell Biol. 2001. PMID: 11389443
-
c-Src couples PI 3 kinase/Akt and MAPK signaling to PDGF-induced DNA synthesis in mesangial cells.Cell Signal. 2006 Nov;18(11):1854-64. doi: 10.1016/j.cellsig.2006.02.003. Cell Signal. 2006. PMID: 16530387
-
STAT activation by the PDGF receptor requires juxtamembrane phosphorylation sites but not Src tyrosine kinase activation.Oncogene. 1999 Jun 17;18(24):3583-92. doi: 10.1038/sj.onc.1202694. Oncogene. 1999. PMID: 10380880
-
Regulation of cell cycle entry and G1 progression by CSF-1.Mol Reprod Dev. 1997 Jan;46(1):11-8. doi: 10.1002/(SICI)1098-2795(199701)46:1<11::AID-MRD3>3.0.CO;2-U. Mol Reprod Dev. 1997. PMID: 8981358 Review.
-
Platelet derived growth factor/tyrosine kinase receptor mediated proliferation.Growth Regul. 1993 Sep;3(3):172-9. Growth Regul. 1993. PMID: 8220110 Review.
Cited by
-
MYC Oncogene: A Druggable Target for Treating Cancers with Natural Products.Aging Dis. 2024 Apr 1;15(2):640-697. doi: 10.14336/AD.2023.0520. Aging Dis. 2024. PMID: 37450923 Free PMC article. Review.
-
Requirement of phospholipase C gamma, the tyrosine phosphatase Syp and the adaptor proteins Shc and Nck for PDGF-induced DNA synthesis: evidence for the existence of Ras-dependent and Ras-independent pathways.EMBO J. 1996 Sep 16;15(18):4940-8. EMBO J. 1996. PMID: 8890167 Free PMC article.
-
MicroRNA-205 inhibits Src-mediated oncogenic pathways in renal cancer.Cancer Res. 2011 Apr 1;71(7):2611-21. doi: 10.1158/0008-5472.CAN-10-3666. Epub 2011 Feb 17. Cancer Res. 2011. PMID: 21330408 Free PMC article.
-
Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc.EMBO J. 1996 Dec 2;15(23):6595-604. EMBO J. 1996. PMID: 8978686 Free PMC article.
-
Ras-independent transformation by v-Src.Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3028-33. doi: 10.1073/pnas.94.7.3028. Proc Natl Acad Sci U S A. 1997. PMID: 9096340 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous